| Section 58-2.22 Reserved |
|
| SubPart 58-8 - Human Immunodeficiency Virus (HIV) Testing |
|
| Section 58-8.4 - HIV result reporting requirements |
|
| GENERAL PROVISIONS |
|
| Section 80.3 - Exceptions, reclassification and exemptions of scheduled controlled substances |
|
| Section 80.135 - Authorization to conduct hypodermic syringe and needle exchange programs |
|
| Section 80.138 - Opioid Overdose Prevention Programs |
|
| Section 86-1.20 - Add-ons to the case payment rate per discharge |
|
| Section 86-1.23 - Exempt units and hospitals |
|
| Section 86-1.45 - Reimbursement for language assistance services in hospital inpatient settings |
|
| Section 86-1.46 - Empire Clinical Research Investigator Program (ECRIP) |
|
| SubPart 86-8 - Outpatient Services: Ambulatory Patient Group |
|
| Section 86-8.4 - Capital reimbursement and rate add-ons |
|
| Section 86-10.1 - Applicability |
|
| Section 86-10.4 - Reporting requirements |
|